Duvelisib: Additional Ph II DYNAMO data

Additional data from the open-label, international Phase II DYNAMO trial in 129 patients with follicular lymphoma (n=83), small lymphocytic lymphoma (SLL) (n=28) or

Read the full 236 word article

User Sign In